Acadia Pharmaceuticals Inc

Ownership Transactions Reported by 18 Insiders

Symbol
ACAD on Nasdaq
Industry
Pharmaceutical Preparations
Location
12830 El Camino Real, Suite 400, San Diego, CA

Insiders trading volume in the past year

Acadia Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director, 10%+ Owner $668M May 29, 2024
Stephen Davis CEO, Director $4.05M -$1.72M -29.8% Aug 16, 2024
Srdjan R. Stankovic President $1.83M Nov 19, 2022
Douglas J. Williamson Executive VP, Research & Dev $1.52M Feb 10, 2023
Austin D. Kim EVP,General Counsel, Secretary $1.41M -$17.7K -1.24% Jan 6, 2024
Brendan Teehan Evp, Coo, Head Of Commercial $1.21M -$553K -31.4% Nov 17, 2024
Mark C. Schneyer Evp, Chief Financial Officer $1.05M -$560K -34.8% Nov 17, 2024
Elizabeth H.Z. Thompson EVP, Head of Research & Dev $955K Aug 12, 2024
Jennifer J. Rhodes Evp, Chief Legal Officer, Sec $776K Feb 6, 2024
Thomas Garner EVP, Chief Commercial Officer $763K Dec 9, 2024
Daniel B. Soland Director $746K May 29, 2024
Edmund Harrigan Director $594K May 29, 2024
James M. Daly Director $577K May 29, 2024
Elizabeth A. Garofalo Director $540K May 29, 2024
Laura Brege Director $500K May 29, 2024
James Kihara Principal Accounting Officer $401K -$135K -25.2% Nov 17, 2024
Adora Ndu Director $236K Oct 12, 2024
Catherine E. Owen Chief Executive Officer, Director Sep 23, 2024

Recent Insider Transactions by Companies or Individuals for Acadia Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.